Mar 6, 2026 04:00PM
Mar 5, 2026 02:11PM
Mar 5, 2026 07:05AM
Mar 3, 2026 09:00AM
Feb 27, 2026 01:10AM
Feb 26, 2026 04:00PM
Feb 26, 2026 11:53AM Stifel: 'We can see why QURE shares are lower on CNBC comments from FDA'
Feb 24, 2026 09:00AM
Feb 23, 2026 03:15AM
Feb 20, 2026 04:19AM
Feb 19, 2026 10:15AM
Feb 18, 2026 05:00PM
Feb 16, 2026 10:54AM
Feb 11, 2026 06:40AM Regenxbio Inc. (RGNX) PT Lowered to $32 at H.C. Wainwright
Feb 9, 2026 04:05PM
Feb 9, 2026 04:05PM
Jan 29, 2026 06:50AM
Jan 29, 2026 04:44AM
Jan 29, 2026 04:26AM
Jan 28, 2026 01:51PM
Jan 28, 2026 07:30AM FDA places clinical hold on REGENXBIO gene therapies after tumor case
Jan 28, 2026 07:30AM
Jan 12, 2026 06:53AM
Jan 11, 2026 03:00PM
Dec 19, 2025 07:44AM
Dec 15, 2025 06:20AM
Nov 6, 2025 07:05AM
Sep 8, 2025 07:14AM H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)
Sep 5, 2025 03:21PM
Sep 5, 2025 11:03AM
Sep 5, 2025 07:05AM
Sep 5, 2025 07:05AM
Aug 19, 2025 06:48AM
Aug 19, 2025 06:40AM
Aug 18, 2025 05:00PM REGENXBIO receives FDA review extension for MPS II gene therapy
Aug 18, 2025 05:00PM
Aug 8, 2025 08:52AM
Aug 7, 2025 07:05AM
Jun 5, 2025 07:05AM
Jun 5, 2025 07:05AM
May 19, 2025 04:05PM
May 19, 2025 04:05PM REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million
May 14, 2025 07:13AM
May 13, 2025 09:24AM
May 13, 2025 07:07AM
May 13, 2025 07:05AM
May 12, 2025 04:05PM
Mar 17, 2025 06:40AM
Mar 13, 2025 04:05PM REGENXBIO Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Updates
Mar 4, 2025 07:31AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All